Vascular Health and Risk Management
Volume 16, 2020 - Issue
Open access
137
Views
9
CrossRef citations to date
0
Altmetric
Review
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date
Xiaoming Jia1 Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
, Stephanie Koh1 Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
, Mahmoud Al Rifai1 Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
https://orcid.org/0000-0002-6933-790X
Roger S Blumenthal2 The Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, USA
& Salim S Virani1 Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA;3 Health Policy, Quality & Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations, Houston, TX, USA;4 Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0001-9541-6954
Pages 1-10
|
Published online: 09 Jan 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.